Private company

Cue Health Inc.

In its 2024 annual report the company says: “We are a health technology company, and our mission is to empower people to live their healthiest lives. We are helping pioneer this healthcare digital transformation, beginning with diagnostics. We started from consumer-centric principles and designed our proprietary platform, the Cue Integrated Care Platform, with a relentless focus on user experience, convenience, and accuracy, with the goal of enabling people to make quicker, better-informed healthcare decisions.”4 It is headquartered in San Diego, California.1

Last updated Oct 20, 2026.

Overview

  • IndustryLaboratory Analytical Instruments1
  • HeadquartersSan Diego, California1
  • Business address4980 Carroll Canyon Road, Suite 100, San Diego, Ca 921212
  • Filer category, Emerging growth company2

We are a health technology company, and our mission is to empower people to live their healthiest lives. Digital transformation has revolutionized nearly every industry to create new, consumer-first experiences that are both personalized and empowering. We seek to usher in a new era in healthcare, what we call Healthcare 2.0, to transform how acute and chronic conditions are diagnosed and managed.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-556.6%Operating margin5
-526.5%Net margin5
-85.3%Revenue growth, 20235
-149.2%Return on equity5
-$147.0MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Research and development96¢$150.6M
  • Interest1¢$1.2M
  • Income tax3¢$4.8M

Out of $70.9M in revenue.5 The company lost money this year.

Financial statements

Revenue675$70.9M in 2023+971% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $6.6M$6.6M20192020: $23.0M$23.0M2020+246%2021: $618.1M$618.1M2021+2593%2022: $483.5M$483.5M2022−22%2023: $70.9M$70.9M2023−85%
Operating income675-$394.9M in 2023+1801% since 2019
-$400.0M-$200.0M0$200.0M2019: -$20.8M-$20.8M20192020: -$45.1M-$45.1M2020+117%2021: $190.2M$190.2M20212022: -$205.7M-$205.7M20222023: -$394.9M-$394.9M2023+92%
Net income675-$373.5M in 2023+1712% since 2019
-$400.0M-$200.0M0$200.0M2019: -$20.6M-$20.6M20192020: -$47.4M-$47.4M2020+130%2021: $86.4M$86.4M20212022: -$194.1M-$194.1M20222023: -$373.5M-$373.5M2023+92%
Fiscal year201820192020202120222023
Revenue$6.6M6$23.0M7$618.1M5$483.5M5$70.9M5
Research and development$21.4M6$28.5M7$42.8M5$171.5M5$150.6M5
Operating income-$20.8M6-$45.1M7$190.2M5-$205.7M5-$394.9M5
Interest$9.8M5$645.0K5$1.2M5
Income before tax$119.2M5-$203.8M5-$368.7M5
Income tax$06$07$32.8M5-$9.7M5$4.8M5
Net income-$20.6M6-$47.4M7$86.4M5-$194.1M5-$373.5M5
Earnings per share-$1.316-$2.907$0.635-$1.315-$2.445
Earnings per share (diluted)-$1.316-$2.907$0.595-$1.315-$2.445
Shares (weighted, basic)52.8M shares5148.0M shares5152.9M shares5
Shares (weighted, diluted)59.6M shares5148.0M shares5152.9M shares5

Compare Cue Health Inc. with another company

Corporate structure

Cue Health Inc. sits at the top of its group. 5 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Cue Health Inc.

  • Tarsadia Capital, LLC Filed SC 13D/A on Cue Health Inc., latest Aug 27, 2024 (5 filings since Sep 11, 2023)
  • Ayub K. Khattak Filed SC 13G/A on Cue Health Inc., latest Feb 14, 2024 (3 filings since Feb 14, 2022)
  • KSP Cue Health Investments, LLC Filed SC 13G/A on Cue Health Inc., latest Feb 9, 2024 (3 filings since Feb 9, 2022)
  • OAKMONT Corp Filed SC 13D on Cue Health Inc., latest Oct 16, 2023 (3 filings since Feb 14, 2022)
  • Decheng Capital Management III (Cayman), LLC Filed SC 13G on Cue Health Inc., latest Feb 14, 2022
  • Sherpa Ventures Fund, LP Filed SC 13G on Cue Health Inc., latest Feb 14, 2022
  • KOCH INDUSTRIES LLC Filed SC 13G on Cue Health Inc., latest Oct 8, 2021
  • Cue Health Inc. San Diego, California
    • CHP HC, LLC Subsidiary · Delaware, United States
    • Cue Health India Private Limited Subsidiary · India
    • Cue Health Sağlik Yazilimi Hizmetleri Limited Şirketi Subsidiary · Turkey
    • TrustedMedRx, LLC Subsidiary · Florida, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Cue Health Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$19.1M7 Dec 31, 2022$5.6M7 Dec 31, 2021+237.9%
Finance-lease assets$4.8M5 Dec 31, 2023$7.3M5 Dec 31, 2022−33.3%
Operating-lease assets (leased space)$78.5M5 Dec 31, 2023$85.3M5 Dec 31, 2022−8.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$80.9M5 Dec 31, 2023$241.5M5 Dec 31, 2022−66.5%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$19.6M5 Dec 31, 2023$16.9M5 Dec 31, 2022+16.5%
Accumulated amortization$13.6M5 Dec 31, 2023$5.7M5 Dec 31, 2022+138.4%
Finite-lived intangibles, net$19.6M5 Dec 31, 2023$16.9M5 Dec 31, 2022+16.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$14.0M5 Dec 31, 2023$82.2M5 Dec 31, 2022−82.9%
Raw materials$70.4M5 Dec 31, 2023$81.0M5 Dec 31, 2022−13.1%
Work in process$5.3M5 Dec 31, 2023$14.3M5 Dec 31, 2022−62.8%
Finished goods$37.8M5 Dec 31, 2023$37.9M5 Dec 31, 2022−0.1%

Leadership

Who has led Cue Health Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (14)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • CHP HC, LLC Delaware3
  • Cue Health India Private Limited India3
  • Cue Health Sağlik Yazilimi Hizmetleri Limited Şirketi Turkey3
  • TrustedMedRx, LLC Florida3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Cue Inc.Dec 29, 2014 to May 16, 20172

Timeline

  1. May 28, 20248-K Ended a material agreement; Bankruptcy or receivership; Listing notice or transfer27
  2. May 16, 20248-K Executive or director change; Shareholder vote; Other events28
  3. May 1, 20248-K Exit or restructuring costs29
  4. Apr 24, 20248-K Executive or director change30
  5. Apr 9, 20248-K Entered a material agreement; Change to shareholders' rights; Other events31
  6. Mar 29, 20248-K Executive or director change32
  7. Mar 27, 2024New chief executive Clint Sever becomes CEO11
  8. Mar 20, 20248-K Executive or director change33
  9. Mar 13, 20248-K Results of operations34
  10. Feb 16, 20248-K Entered a material agreement; Executive or director change35
  11. Jan 25, 20248-K Exit or restructuring costs36
  12. Jan 5, 20248-K Exit or restructuring costs; Other events37
  13. Nov 8, 20238-K Results of operations38
  14. Sep 23, 2021New chief executive Ayub K. Khattak becomes CEO12

Calendar

When it reported results

  1. Mar 13, 2024Reported quarterly or annual results34
  2. Nov 8, 2023Reported quarterly or annual results38
  3. Aug 9, 2023Reported quarterly or annual results39
  4. May 10, 2023Reported quarterly or annual results40
  5. Mar 15, 2023Reported quarterly or annual results41
  6. Nov 9, 2022Reported quarterly or annual results42
  7. Aug 10, 2022Reported quarterly or annual results43
  8. May 11, 2022Reported quarterly or annual results44

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

199 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 39 major events, 114 insider forms, 17 large holders, 18 other. The latest 20:

  1. Aug 27, 2024SC 13D/A CUE HEALTH INC. EDGAR
  2. Aug 27, 20244 EDGAR
  3. May 28, 20248-K EDGAR
  4. May 21, 20244/A EDGAR
  5. May 17, 2024SC 13D/A EDGAR
  6. May 16, 20248-K EDGAR
  7. May 16, 2024NT 10-Q EDGAR
  8. May 1, 20248-K EDGAR
  9. Apr 24, 20248-K EDGAR
  10. Apr 22, 2024ARS EDGAR
  11. Apr 22, 2024DEF 14A EDGAR
  12. Apr 12, 2024PRE 14A EDGAR
  13. Apr 9, 20248-K EDGAR
  14. Apr 9, 20248-A12B/A EDGAR
  15. Mar 29, 20248-K EDGAR
  16. Mar 27, 20244 EDGAR
  17. Mar 20, 20248-K EDGAR
  18. Mar 13, 2024S-8 EDGAR
  19. Mar 13, 202410-K EDGAR
  20. Mar 13, 20248-K EDGAR

The 199 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

37 open-market trades by officers, directors and large owners since October 2021: 0 buys and 37 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 27, 2024TFC Manager, LLC10% ownerSale3,319,000Form 4
Aug 23, 2024TFC Manager, LLC10% ownerSale14,983,244Form 4
Dec 8, 2022Sever ClintChief Executive OfficerSale29,269$3.02$88.4KForm 4
Dec 7, 2022Sever ClintChief Executive OfficerSale24,147$2.98$72.0KForm 4
Dec 6, 2022Sever ClintChief Executive OfficerSale26,664$3.14$83.7KForm 4
Nov 30, 2022Sever ClintChief Executive OfficerSale22,725$3.11$70.7KForm 4
Nov 25, 2022Sever ClintChief Executive OfficerSale19,089$2.48$47.3KForm 4
Nov 23, 2022Sever ClintChief Executive OfficerSale19,089$2.58$49.2KForm 4
Nov 22, 2022Sever ClintChief Executive OfficerSale19,089$2.56$48.9KForm 4
Nov 10, 2022Sever ClintChief Executive OfficerSale26,664$3.94$105.1KForm 4
Nov 9, 2022Sever ClintChief Executive OfficerSale26,664$3.73$99.5KForm 4
Nov 8, 2022Sever ClintChief Executive OfficerSale26,664$3.81$101.6KForm 4
Oct 27, 2022Sever ClintChief Executive OfficerSale26,664$3.63$96.8KForm 4
Oct 26, 2022Sever ClintChief Executive OfficerSale26,664$3.70$98.7KForm 4
Oct 25, 2022Sever ClintChief Executive OfficerSale26,664$3.51$93.6KForm 4
Oct 13, 2022Sever ClintChief Executive OfficerSale26,664$3.30$88.0KForm 4
Oct 12, 2022Sever ClintChief Executive OfficerSale26,664$3.24$86.4KForm 4
Oct 11, 2022Sever ClintChief Executive OfficerSale26,664$3.32$88.5KForm 4
Sep 30, 2022Sever ClintChief Executive OfficerSale7,374$3.03$22.3KForm 4
Sep 29, 2022Sever ClintChief Executive OfficerSale19,290$2.94$56.7KForm 4

All 37 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Cue Health Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCue Health Inc.1
  • CIK0001628945
  • Employer ID (EIN)27-15621931
  • Filer status<br>emerging growth company1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3826 Laboratory Analytical Instruments1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address4980 Carroll Canyon Road, Suite 100, San Diego, CA 921211
  • Phone(858) 412-81511
  • Shares outstanding158,516,303 as of Mar 4, 20245
  • Public float$50.0M as of Jun 30, 20235
  • On EDGAR sinceDec 29, 20141
  • Filings255 in all: 4 (119), 8-K (39), 3 (20), 10-Q (7), CORRESP (6), SC 13G/A (6), SC 13G (5), UPLOAD (5)1
    All 35 form types

    S-8 (4), SC 13D/A (4), 10-K (3), D (3), DEF 14A (3), 4/A (2), 8-A12B (2), ARS (2), DRS/A (2), DRSLTR (2), EFFECT (2), S-1/A (2), SC 13D (2), SEC STAFF LETTER (2), 10-K/A (1), 25-NSE (1), 424B4 (1), 424B5 (1), 8-A12B/A (1), 8-K/A (1), CERT (1), DRS (1), NT 10-Q (1), PRE 14A (1), S-1 (1), S-3 (1), S-3/A (1)

  • Latest filingsAnnual report (10-K) Mar 13, 2024
    Quarterly report (10-Q) Nov 8, 2023
    Proxy statement (DEF 14A) Apr 22, 2024
    Latest 8-K (8-K) May 28, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51